JP2024543187A - タウタンパク質の異常リン酸化及び凝集の阻害物質 - Google Patents
タウタンパク質の異常リン酸化及び凝集の阻害物質 Download PDFInfo
- Publication number
- JP2024543187A JP2024543187A JP2024531728A JP2024531728A JP2024543187A JP 2024543187 A JP2024543187 A JP 2024543187A JP 2024531728 A JP2024531728 A JP 2024531728A JP 2024531728 A JP2024531728 A JP 2024531728A JP 2024543187 A JP2024543187 A JP 2024543187A
- Authority
- JP
- Japan
- Prior art keywords
- formula
- compound
- tau
- nmr
- sulfonic acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/02—Acyclic radicals, not substituted by cyclic structures
- C07H15/12—Acyclic radicals, not substituted by cyclic structures attached to a nitrogen atom of the saccharide radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/02—Acyclic radicals, not substituted by cyclic structures
- C07H15/04—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
- A61K31/7032—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a polyol, i.e. compounds having two or more free or esterified hydroxy groups, including the hydroxy group involved in the glycosidic linkage, e.g. monoglucosyldiacylglycerides, lactobionic acid, gangliosides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Crystallography & Structural Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Biochemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Genetics & Genomics (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Epidemiology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP21306658.2 | 2021-11-29 | ||
| EP21306658 | 2021-11-29 | ||
| PCT/EP2022/083709 WO2023094699A1 (fr) | 2021-11-29 | 2022-11-29 | Inhibiteurs de la phosphorylation anormale et de l'agrégation de la protéine tau |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024543187A true JP2024543187A (ja) | 2024-11-19 |
| JP2024543187A5 JP2024543187A5 (cg-RX-API-DMAC10.html) | 2025-11-28 |
Family
ID=78851140
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024531728A Pending JP2024543187A (ja) | 2021-11-29 | 2022-11-29 | タウタンパク質の異常リン酸化及び凝集の阻害物質 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20250034194A1 (cg-RX-API-DMAC10.html) |
| EP (1) | EP4441064A1 (cg-RX-API-DMAC10.html) |
| JP (1) | JP2024543187A (cg-RX-API-DMAC10.html) |
| CN (1) | CN118922429A (cg-RX-API-DMAC10.html) |
| CA (1) | CA3240163A1 (cg-RX-API-DMAC10.html) |
| WO (1) | WO2023094699A1 (cg-RX-API-DMAC10.html) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20240409505A1 (en) * | 2023-06-12 | 2024-12-12 | The Procter & Gamble Company | Gluconamide sulfate surfactants |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5686603A (en) * | 1995-05-04 | 1997-11-11 | Lever Brothers Company, Division Of Conopco, Inc. | Sulfated polyhydroxy compounds as anionic surfactants and a process for their manufacture |
| WO2007115372A1 (en) * | 2006-04-10 | 2007-10-18 | Monash University | A method of modulating beta-amyloid peptide production |
-
2022
- 2022-11-29 CA CA3240163A patent/CA3240163A1/fr active Pending
- 2022-11-29 JP JP2024531728A patent/JP2024543187A/ja active Pending
- 2022-11-29 WO PCT/EP2022/083709 patent/WO2023094699A1/fr not_active Ceased
- 2022-11-29 CN CN202280089714.7A patent/CN118922429A/zh active Pending
- 2022-11-29 EP EP22823041.3A patent/EP4441064A1/fr active Pending
- 2022-11-29 US US18/714,018 patent/US20250034194A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| CN118922429A (zh) | 2024-11-08 |
| US20250034194A1 (en) | 2025-01-30 |
| CA3240163A1 (fr) | 2023-06-01 |
| WO2023094699A1 (fr) | 2023-06-01 |
| EP4441064A1 (fr) | 2024-10-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022520518A (ja) | パンテテイン誘導体及びその使用 | |
| HU193151B (en) | Process for producing ganglyoside derivatives and pharmaceutical compositions containing them as active agents | |
| US20220249411A1 (en) | Calixarene compounds and uses thereof | |
| JP2016536360A (ja) | パントテン酸キナーゼ関連神経変性症(pkan)の治療のための安定なパンテテイン誘導体およびそのような化合物の合成方法 | |
| CA3146157A1 (en) | Sulfone compounds and pharmaceutical compositions thereof, and their therapeutic applications for the treatment of neurodegenerative diseases | |
| TW201241005A (en) | Methods for synthesizing molybdopterin precursor Z derivatives | |
| US20250034194A1 (en) | Inhibitors of abnormal phosphorylation and tau protein aggregation | |
| CN111494380B (zh) | Db-1在制备防治nlrp3炎症小体相关疾病的药物中的应用及其药物组合物 | |
| JP2009527563A (ja) | ウイルス感染症を治療するのに有用な置換タラキサスタン | |
| CN112218878A (zh) | Ntcp抑制剂 | |
| JPH02200697A (ja) | リゾガングリオシド誘導体 | |
| JP2008529998A (ja) | トポイソメラーゼII触媒インヒビターとしての6−エーテル/チオエーテル−プリンおよび療法(therapy)におけるその用途 | |
| KR20180101416A (ko) | Cftr 조절제 및 이의 이용 방법 | |
| JP2025505975A (ja) | ニコチネート及びニコチンアミドリボシドベースの化合物及びその誘導体 | |
| TWI803858B (zh) | 化合物及其醫藥用途 | |
| US20190211059A1 (en) | Novel compounds for the treatment of neurodegenerative diseases | |
| KR20090074226A (ko) | 혈액응고를 방해하는 화합물 | |
| JP2004083465A (ja) | Smアーゼインヒビターとしてのシホスタチンアナログ | |
| JP6353849B2 (ja) | Bace−1の阻害剤としての糖樹状クラスター化合物 | |
| US20150191446A1 (en) | Seleno-compounds and therapeutic uses thereof | |
| HU208834B (en) | Process for producing dilysoganglioside derivatives and pharmaceutical compositions comprising such active ingredient | |
| AU2017405304B2 (en) | Heparan sulfate glycomimetic compounds and their pharmaceutical and cosmeceutical uses | |
| CN104557897A (zh) | 法舒地尔-硫辛酸二联体的合成及其应用 | |
| ES2629019T3 (es) | Derivado de tiazinamida y composición farmacéutica y uso de los mismos | |
| CN121270649A (zh) | 一类万古霉素衍生物、其制备方法、药物组合物和用途 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20251117 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20251117 |